These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Immunity and immunosuppression in tumor growth]. Govallo VI Vopr Onkol; 1987; 33(4):91-9. PubMed ID: 3296437 [No Abstract] [Full Text] [Related]
3. [On the criticism of antitumor immunity: arguments for and against]. Revskoĭ SIu; Dil'man VM Vopr Onkol; 1988; 34(4):477-81. PubMed ID: 3287765 [No Abstract] [Full Text] [Related]
4. Cancer immunology--an overview. Richards V Prog Exp Tumor Res; 1980; 25():1-60. PubMed ID: 6986628 [No Abstract] [Full Text] [Related]
5. [Radiotherapy and antitumor immunity. Immunomodifying action of ionizing radiation]. Klimovich VB Med Radiol (Mosk); 1983 Jul; 28(7):77-84. PubMed ID: 6224065 [No Abstract] [Full Text] [Related]
6. [A new hypothesis on the immune surveillance of tumors]. Jansa P Acta Univ Palacki Olomuc Fac Med; 1984; 107():139-42. PubMed ID: 6242634 [No Abstract] [Full Text] [Related]
7. [Regulation of immunological response by macrophages]. Ptak W; Marcinkiewicz J Postepy Hig Med Dosw; 1981; 35(1):1-35. PubMed ID: 7038646 [No Abstract] [Full Text] [Related]
8. The gordian knot of tumour immunology. Amlot P Guys Hosp Rep; 1974; 123(1):43-51. PubMed ID: 4549511 [No Abstract] [Full Text] [Related]
9. [Cytotoxic cells of the NK type - their characteristics and role in anti-neoplastic immunity]. Janiak M; Lipski S Postepy Hig Med Dosw; 1982; 36(1-3):95-131. PubMed ID: 6763997 [No Abstract] [Full Text] [Related]
10. [Immunoreactivity in tumor growth]. Fel' VIa Vopr Onkol; 1987; 33(4):99-106. PubMed ID: 3296438 [No Abstract] [Full Text] [Related]
11. Genes coding for tumor rejection antigens: perspectives for specific immunotherapy. Boon T; Coulie P; Marchand M; Weynants P; Wölfel T; Brichard V Important Adv Oncol; 1994; ():53-69. PubMed ID: 8206495 [No Abstract] [Full Text] [Related]
12. [Immunology and cancer]. Brunner KT Schweiz Med Wochenschr; 1973 Sep; 103(36):1249-52. PubMed ID: 4584090 [No Abstract] [Full Text] [Related]
13. Cancer in immunosuppressed experimental animals and human patients. Allison AC Johns Hopkins Med J Suppl; 1974; 3():341-51. PubMed ID: 4370940 [No Abstract] [Full Text] [Related]
14. On immunosurveillance in human cancer. Thomas L Yale J Biol Med; 1982; 55(3-4):329-33. PubMed ID: 6758376 [TBL] [Abstract][Full Text] [Related]
15. [Immunological properties of tumor cells that determine the degree of their malignancy]. Lavrovskiĭ VA; Viksler VKh Usp Sovrem Biol; 1981; 91(2):228-40. PubMed ID: 7018110 [No Abstract] [Full Text] [Related]
16. [Immunosuppression mechanism affecting the development of neoplasms]. Rupniewska ZM; Kurowska M Pol Tyg Lek; 1980 Mar; 35(12):455-7. PubMed ID: 6966796 [No Abstract] [Full Text] [Related]
17. Tumor-associated and spontaneous lymphocyte-mediated cytotoxicity against cell lines derived from human urothelium. Vilien M Dan Med Bull; 1985 Aug; 32(4):199-218. PubMed ID: 3899526 [No Abstract] [Full Text] [Related]
18. [Tumor genesis as an immunologic problem]. Rapp W Med Welt; 1972 May; 23(21):788-92. PubMed ID: 5040396 [No Abstract] [Full Text] [Related]
19. Promises and limitations of murine models in the development of anticancer T-cell vaccines. Lévy F; Colombetti S Int Rev Immunol; 2006; 25(5-6):269-95. PubMed ID: 17169777 [TBL] [Abstract][Full Text] [Related]
20. [Antitumor immunoadjuvant activity and the immunoregulatory mechanisms of yeasts and their components]. Marconi P; Bistoni F Ann Ist Super Sanita; 1982; 18(3):501-8. PubMed ID: 6765083 [No Abstract] [Full Text] [Related] [Next] [New Search]